Krystal Biotech, Inc. Common Stock
KRYS
Jodie situation report
Krystal Biotech, Inc. Common Stock's current read is isolated; its market group is not confirming.
The latest filing evidence is available. 0 of 9 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 12 directly disclosed connections are confirming.
- Revenue increased 31.9% versus the comparable filing period.
- Reported increase in R&D costs driven by timing of production runs for KB111, KB407, and KB803 and higher unallocated materials for pipeline products.
Invalidation: The isolated read changes if KRYS's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind KRYS
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
ALNYAlnylam Pharmaceuticals, Inc.partnerFeb 17, 2026 ▾
“These can be generally classified into four broad categories: • Gene Silencing Approaches: We are aware of two companies, Takeda Pharmaceutical Company Limited (in partnership with Arrowhead Pharmaceutical Inc.) and Novo Nordisk A/S (in partnership with Alnyl…”
BBIOBridgeBio Pharma, Inc.partnerFeb 17, 2026 ▾
“We are also aware of a recombinant-protein-based approach being developed by BridgeBio Pharma, Inc.’s affiliate company, Phoenix Tissue Repair.”
Depended on by
FDMT4D Molecular Therapeutics, Inc.competitorMar 18, 2026 ▾
“We consider our most direct competitors with respect to 4D-710 for the treatment of CF lung disease to be Vertex Pharmaceuticals Incorporated, which has several approved CFTR modulators, as well as other companies in preclinical/early-clinical development of…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 9 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
KRYS is currently a Follower in the organic co-movement group Biotechnology. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.